Targeting the E3 ubiquitin ligase RNF10 ameliorates metabolic dysfunction–associated steatohepatitis in mice
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci194148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Chunyuan Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key Laboratory of Cellular Homeostasis and Disease, Department…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Fatty Liver, Hepatocytes. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Metabolic dysfunction–associated steatotic liver disease (MASLD) has emerged as a global health concern. Nevertheless, its underlying pathological mechanisms remain poorly understood. Here, we showed that E3 ubiquitin ligase RING finger protein 10 (RNF10) protein levels were positively correlated with MASLD in both mice and humans. Hepatocyte-specific Rnf10 deletion attenuated liver steatosis, inflammation, and fibrosis. Conversely, adeno-associated virus–mediated hepatocyte-specific Rnf10 overexpression exacerbated MASLD-related phenotypes. Mechanistically, RNF10 interacted with carnitine palmitoyltransferase 1A and facilitated its degradation through K48-linked ubiquitination, thereby inhibiting fatty acid oxidation, promoting hepatic lipid accumulation, and ultimately exacerbating liver inflammation and fibrosis. Moreover, we utilized triantennary N -acetylgalactosamine to deliver siRNA specifically targeting Rnf10 to hepatocytes. This approach effectively ameliorated diet-induced liver steatosis, inflammation, and fibrosis in mice. Therefore, interfering with the expression or function of RNF10 may be a promising therapeutic strategy for MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key Laboratory of Cellular Homeostasis and Disease, Department of Physiology and Pathophysiology, School of Basic Medical Sciences,…
- Department of Gastroenterology, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
- Obesity and Metabolism Medicine-Engineering Integration Laboratory and.
- Center of Gastrointestinal and Minimally Invasive Surgery, Department of General Surgery, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Discipline Research Special Project of Tianjin Medical University
Zitieren
APA
Du, C., Zhang, Y., Chang, H., Xu, C., Sheng, S., Xu, K., Qiao, W., Liu, Y., Zhang, T., Gao, Y., Li, P., & Chang, Y. (2026). Targeting the E3 ubiquitin ligase RNF10 ameliorates metabolic dysfunction–associated steatohepatitis in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci194148
Vancouver
Du C, Zhang Y, Chang H, Xu C, Sheng S, Xu K, et al. Targeting the E3 ubiquitin ligase RNF10 ameliorates metabolic dysfunction–associated steatohepatitis in mice. Journal of Clinical Investigation. 2026. doi:10.1172/jci194148
BibTeX
@article{Du2026,
author = {Du, Chunyuan and Zhang, Yinliang and Chang, Hongkai and Xu, Chaofan and Sheng, Sufang and Xu, Ke and Qiao, Wei and Liu, Yanjun and Zhang, Tongtong and Gao, Yong and Li, Peng and Chang, Yongsheng},
title = {Targeting the E3 ubiquitin ligase RNF10 ameliorates metabolic dysfunction–associated steatohepatitis in mice},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci194148}
}
EUVIMED